A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...
2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...
Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for ...
Congratulations to Michael McCrary (shown left in photo), Entrepreneur-in-Residence at the School of Management, and his ...
Medical technology, the pharmaceutical industry and biotechnology are sectors in which sensors and measurement technology are increasingly being used to improve quality and efficiency. Micro-Epsilon ...
UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...
Viridian Therapeutics, Inc. , a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines for serious and rare diseases, today announced the ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.
Investor's Business Daily on MSN
Stock Market Powers Higher Amid Huge Earnings, Federal Reserve, Trump-Xi: Weekly Review
The stock market had strong weekly gains after huge earnings, the latest Federal Reserve move and a Trump-Xi meeting.
In this exclusive interview, Panda Biotech’s President Dixie Carter outlines how U.S.-grown, cottonized hemp is moving from ...
In a pop-up city off the coast of Honduras, longevity startups are trying to fast-track anti-aging drugs. Is this the future ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback